Title

Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer

Authoring Organization

Publication Month/Year

December 8, 2021

Document Type

Guideline

Country of Publication

US

Target Patient Population

Patients with nonmetastatic breast cancer

Target Provider Population

Medical oncologists, surgical oncologists, radiologists, pathologists, oncology nurses, patients or caregivers or advocates

Inclusion Criteria

Female, Adult, Older adult

Health Care Settings

Ambulatory, Outpatient, Radiology services

Scope

Treatment, Management

Diseases/Conditions (MeSH)

D001943 - Breast Neoplasms, D017024 - Chemotherapy, Adjuvant

Keywords

breast cancer, chemotherapy, endocrine therapy, HER2-targeted therapy, Targeted Therapy

Source Citation

Korde LA, Somerfield MR, Carey LA, Crews JR, Denduluri N, Hwang ES, Khan SA, Loibl S, Morris EA, Perez A, Regan MM, Spears PA, Sudheendra PK, Symmans WF, Yung RL, Harvey BE, Hershman DL. Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline. J Clin Oncol. 2021 May 1;39(13):1485-1505. doi: 10.1200/JCO.20.03399. Epub 2021 Jan 28. PMID: 33507815; PMCID: PMC8274745.